The US develops a vaccine to deal with a new CoV strain
The US develops a vaccine to deal with a new CoV strain news Debbie Elrick 29 Jan 2021 (89) The US company Novavax developed the Covid-19 vaccine that was 89.3 percent effective in the Phase Three trial in the UK, but at a lower rate with the South African strain. Novavax's two-injected NVV-CoV2373 vaccine is also highly effective with the new CoV variant recently discovered in the UK. Covid-19 vaccine from the American biotechnology company Novavax Photo: Reuters ...
Romel Cinco
Muhammad Ramzan
Fatimah Amin Cory Cruz
Marietjie Michelle Smit
Mohit Jain
Angela Akenson
Cathi Collins Mikutis
Mark Grisham
Lady-Lynda Leigh McKie
Joe Farrell
Majid Khichi
Carrington Keys
Julie Ann Hadoc Torio
Sou La
Terrie Hansen